Alida Biosciences Inc. – Trademark Portfolio
Entity Type: 03
Alida Biosciences Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 11 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 8 are pending. Notable registered marks include EPIPLEX and ALIDA BIOSCIENCES. The owner is based in San Diego, CA.
14813 Priscilla St
San Diego, CA 92129
Showing of trademarks Trademarks
Trademark Classifications
Alida Biosciences Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Alida Biosciences Inc. have?
Alida Biosciences Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 8 pending, 1 abandoned.
What trademark classes does Alida Biosciences Inc. file in?
Alida Biosciences Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Alida Biosciences Inc.'s most well-known trademarks?
Alida Biosciences Inc.'s registered trademark portfolio includes well-known marks such as EPIPLEX and ALIDA BIOSCIENCES. These are among 2 currently registered trademarks in the portfolio.
What is Alida Biosciences Inc.'s trademark registration success rate?
Alida Biosciences Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 8 applications are pending review.